Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults
Clinical trial NCT01262976 · COMPLETED
Trial details
- NCT number
- NCT01262976
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-17
- Primary completion
- 2012-07-17
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.